Table 1. Data of the 89 Patients at... | American Society of Hematology

Table 1.

Data of the 89 Patients at Stopping Chemotherapy

	HBV Group	HCV Group	HBV-HCV Group
No. of patients	46	11	32
Male/female	20/26	4/7	18/14
Median age; yr (range)	6 (1-13)	7 (3-16)	7 (3-14)
Patients with elevated ALT^*	20	7	23
Median ALT × UNL (range)	2.4 (1.5-6.8)	2.0 (1.5-21)	3.0 (1.8-9.2)
Transfusion/surgery^†	26/11	10/1	28/2

	HBV Group	HCV Group	HBV-HCV Group
No. of patients	46	11	32
Male/female	20/26	4/7	18/14
Median age; yr (range)	6 (1-13)	7 (3-16)	7 (3-14)
Patients with elevated ALT^*	20	7	23
Median ALT × UNL (range)	2.4 (1.5-6.8)	2.0 (1.5-21)	3.0 (1.8-9.2)
Transfusion/surgery^†	26/11	10/1	28/2

ALT ≥ 1.5 × upper normal limit.

†

Number of patients who received transfusion and/or surgery in each group. In 9 patients of HBV group and in 2 of the HBV-HCV group, no evidence of sources of infection was found.

View Large

This Feature Is Available To Subscribers Only